What ICD‑10 diagnosis codes should be used to justify ordering hormone labs (total testosterone and estradiol) for a male patient on testosterone therapy who is also taking anastrozole?

ICD-10 Codes for Testosterone and Estradiol Labs in Males on Testosterone Therapy with Anastrozole

For a male patient on testosterone therapy who is also taking anastrozole, use E29.1 (Testicular hypogonadism) as the primary diagnosis code to justify ordering total testosterone and estradiol labs.

Primary Diagnosis Code

• E29.1 - Testicular hypogonadism (primary hypogonadism)
  • This code covers males with documented testosterone deficiency requiring replacement therapy 1
  • Appropriate when the patient has established hypogonadism with low testosterone levels confirmed on two separate morning measurements 1

Alternative/Additional Codes Depending on Clinical Context

• E29.8 - Other testicular dysfunction

  • Can be used for functional hypogonadism or when the specific etiology is unclear

• E23.0 - Hypopituitarism (secondary hypogonadism)

  • Use this if the patient has documented hypothalamic-pituitary dysfunction rather than primary testicular failure 1
  • Important distinction: secondary hypogonadism has different therapeutic implications regarding fertility 1

Monitoring Rationale

The anastrozole component is critical here - this aromatase inhibitor is being used to manage elevated estradiol levels that can occur during testosterone therapy 2, 3. The lab monitoring serves to:

• Ensure testosterone levels remain therapeutic (typically 300-1000 ng/dL range)
• Verify estradiol suppression to appropriate levels (generally <60 pg/mL, or <40 pg/mL if symptomatic) 2
• Monitor the testosterone-to-estradiol ratio, which should ideally be >10 4, 5

Common Pitfalls to Avoid

• Don't use Z79.890 (hormone replacement therapy) as the primary code - this is supplementary and won't justify the medical necessity of hormone monitoring
• Avoid E34.9 (endocrine disorder, unspecified) - this is too vague and may result in claim denials
• The distinction between primary (E29.1) and secondary (E23.0) hypogonadism matters clinically and for coding accuracy 1

Documentation Tips

Ensure your medical record clearly documents:

• Original diagnosis of hypogonadism with baseline testosterone levels
• Indication for anastrozole (elevated estradiol or symptoms of excess estrogen on testosterone therapy)
• That monitoring is for therapeutic drug management and dose optimization

The evidence supports that approximately 3% of men on testosterone therapy require aromatase inhibitor co-administration for elevated estradiol management 2, making this a medically necessary monitoring scenario.